Henrik Fuglsang is an author at Novozymes (Denmark) specializing in drug resistance, drug development, and drug discovery.
Top concepts
MedicinePharmacologyDrug DiscoveryDrug ResistanceDrug DevelopmentMedicinal ChemistryPharmacotherapy
Publications per year
2005–2006
2
2
Rows per page
1–2 of 2